معرفی
Brian V. Jones serves as an Associate Professor in the Department of Life Sciences within the Faculty of Science at the University of Bath. His research focuses on medical microbiology with particular emphasis on biofilm formation, urinary tract infections, and antimicrobial resistance. He maintains an active research program with multiple ongoing projects related to catheter-associated infections and biofilm control.
Dr. Jones' research interests span several interconnected areas of medical microbiology. His primary focus is on Proteus mirabilis and its role in catheter-associated urinary tract infections, with significant work on biofilm formation and mechanisms of antimicrobial resistance. His laboratory investigates bacterial pathogenesis related to medical devices, particularly urinary catheters, and explores novel approaches to prevent biofilm-related complications. Additional research interests include metagenomics of the gut microbiome and bacteriophage applications for infection control.
Analysis of Dr. Jones' recent publications reveals a strong focus on translational medical microbiology with direct clinical applications. His work consistently addresses the challenges of biofilm formation on medical devices, particularly urinary catheters, and investigates mechanisms of antimicrobial tolerance in pathogenic bacteria. The research combines molecular microbiology techniques with clinical sample analysis to develop practical solutions for healthcare-associated infections. His publications demonstrate a clear progression from basic mechanistic studies toward applied solutions for medical device-related infections.
Dr. Jones actively supervises doctoral students and has served as an external examiner for PhD vivas at Queen's University Belfast in 2021 and 2025. His research is supported by multiple grants from organizations including the National Biofilms Innovation Centre, Dunhill Medical Trust, and the Biotechnology and Biological Sciences Research Council.
His current research portfolio includes eight projects, with one active project through August 2025 focused on developing encrustation-resistant urinary catheters. Other significant projects include controlling catheter biofilm formation through drug repurposing, commercialization of burn wound biofilm models, and infection-responsive theranostic catheter coatings.
